Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sunitinib Malate for the Therapy of Progressive Metastatic Androgen Independent Prostate Cancer (AIPC) Following Docetaxel-based Chemotherapy

NCT00599313 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00599313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00599313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sunitinib Malate for the Therapy of Progressive Metastatic Androgen Independent Prostate Cancer (AIPC) Following Docetaxel-based Chemotherapy
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
June 30, 2009
Enrollment
36 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer